A Semi-Mechanistic Modeling approach to support Phase III dose selection for TAK-875 Integrating Glucose and HbA1c Data

Therapeutic area :

Stringer F., Matsuno K., Snelder N. and Hirayama M., A Semi-Mechanistic Modeling approach to support Phase III dose selection for TAK-875 Integrating Glucose and HbA1c Data in Japanese Type 2 Diabetes Patients. PAGE.(2013)  [Link to publication]